Annual D&A
$8.28 B
+$1.57 B+23.45%
31 December 2023
Summary:
Novartis AG annual depreciation & amortization is currently $8.28 billion, with the most recent change of +$1.57 billion (+23.45%) on 31 December 2023. During the last 3 years, it has risen by +$1.81 billion (+28.05%). NVS annual D&A is now at all-time high.NVS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$1.97 B
+$803.00 M+69.10%
30 September 2024
Summary:
Novartis AG quarterly depreciation & amortization is currently $1.97 billion, with the most recent change of +$803.00 million (+69.10%) on 30 September 2024. Over the past year, it has dropped by -$1.15 billion (-36.84%). NVS quarterly D&A is now -56.65% below its all-time high of $4.53 billion, reached on 30 September 2017.NVS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$6.03 B
-$1.15 B-15.97%
30 September 2024
Summary:
Novartis AG TTM depreciation & amortization is currently $6.03 billion, with the most recent change of -$1.15 billion (-15.97%) on 30 September 2024. Over the past year, it has dropped by -$2.48 billion (-29.16%). NVS TTM D&A is now -29.16% below its all-time high of $8.51 billion, reached on 30 September 2023.NVS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVS Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.4% | -36.8% | -29.2% |
| 3 y3 years | +28.1% | +35.2% | -2.9% |
| 5 y5 years | +58.8% | +40.2% | +9.1% |
NVS Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +47.9% | -36.8% | +95.9% | -29.2% | +13.7% |
| 5 y | 5 years | at high | +58.8% | -36.8% | +95.9% | -29.2% | +13.7% |
| alltime | all time | at high | +1017.0% | -56.6% | +409.9% | -29.2% | +1883.2% |
Novartis AG Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.97 B(+69.1%) | $6.03 B(-16.0%) |
| June 2024 | - | $1.16 B(-11.6%) | $7.17 B(-7.1%) |
| Mar 2024 | - | $1.31 B(-17.3%) | $7.72 B(-6.7%) |
| Dec 2023 | $8.28 B(+23.4%) | $1.59 B(-49.0%) | $8.28 B(-2.7%) |
| Sept 2023 | - | $3.11 B(+82.1%) | $8.51 B(+20.3%) |
| June 2023 | - | $1.71 B(-8.7%) | $7.08 B(-1.3%) |
| Mar 2023 | - | $1.87 B(+2.6%) | $7.17 B(+6.9%) |
| Dec 2022 | $6.71 B(+19.8%) | $1.82 B(+8.7%) | $6.71 B(+13.9%) |
| Sept 2022 | - | $1.68 B(-7.0%) | $5.89 B(+3.9%) |
| June 2022 | - | $1.80 B(+28.3%) | $5.66 B(+6.7%) |
| Mar 2022 | - | $1.41 B(+40.1%) | $5.30 B(-5.2%) |
| Dec 2021 | $5.60 B(-13.4%) | $1.00 B(-31.0%) | $5.60 B(-9.9%) |
| Sept 2021 | - | $1.45 B(+0.6%) | $6.21 B(-4.3%) |
| June 2021 | - | $1.44 B(-14.9%) | $6.49 B(-3.8%) |
| Mar 2021 | - | $1.70 B(+4.9%) | $6.75 B(+4.4%) |
| Dec 2020 | $6.46 B(+11.0%) | $1.62 B(-6.7%) | $6.46 B(-4.7%) |
| Sept 2020 | - | $1.73 B(+1.8%) | $6.78 B(+5.1%) |
| June 2020 | - | $1.70 B(+20.8%) | $6.45 B(+11.3%) |
| Mar 2020 | - | $1.41 B(-27.2%) | $5.79 B(-0.5%) |
| Dec 2019 | $5.83 B(+11.8%) | $1.94 B(+38.2%) | $5.83 B(+5.4%) |
| Sept 2019 | - | $1.40 B(+34.0%) | $5.53 B(+0.7%) |
| June 2019 | - | $1.05 B(-27.4%) | $5.49 B(-2.8%) |
| Mar 2019 | - | $1.44 B(-11.9%) | $5.65 B(+8.4%) |
| Dec 2018 | $5.21 B(+10.0%) | $1.64 B(+19.9%) | $5.21 B(+37.9%) |
| Sept 2018 | - | $1.36 B(+13.3%) | $3.78 B(-45.6%) |
| June 2018 | - | $1.21 B(+19.9%) | $6.95 B(+21.0%) |
| Mar 2018 | - | $1.00 B(+395.1%) | $5.74 B(+21.2%) |
| Dec 2017 | $4.74 B(-21.6%) | $203.00 M(-95.5%) | $4.74 B(-24.0%) |
| Sept 2017 | - | $4.53 B(+166.6%) | $6.23 B(+3.1%) |
| Dec 2016 | $6.04 B(+10.5%) | $1.70 B(+12.7%) | $6.04 B(+6.6%) |
| Sept 2016 | - | $1.51 B(+2.9%) | $5.67 B(+2.8%) |
| June 2016 | - | $1.47 B(+7.1%) | $5.51 B(-0.8%) |
| Mar 2016 | - | $1.37 B(+3.3%) | $5.56 B(+1.6%) |
| Dec 2015 | $5.47 B(+16.9%) | $1.32 B(-2.2%) | $5.47 B(+1.9%) |
| Sept 2015 | - | $1.35 B(-10.2%) | $5.37 B(+3.6%) |
| June 2015 | - | $1.51 B(+17.7%) | $5.18 B(+6.9%) |
| Mar 2015 | - | $1.28 B(+4.9%) | $4.85 B(+3.5%) |
| Dec 2014 | $4.68 B | $1.22 B(+4.7%) | $4.68 B(+1.5%) |
| Sept 2014 | - | $1.17 B(-0.7%) | $4.61 B(+1.5%) |
| June 2014 | - | $1.18 B(+5.1%) | $4.54 B(+5.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | $1.12 B(-3.1%) | $4.33 B(-1.7%) |
| Dec 2013 | $4.41 B(-0.8%) | $1.15 B(+5.2%) | $4.41 B(+6.8%) |
| Sept 2013 | - | $1.10 B(+14.3%) | $4.12 B(-3.2%) |
| June 2013 | - | $960.00 M(-19.6%) | $4.26 B(-5.2%) |
| Mar 2013 | - | $1.19 B(+36.9%) | $4.49 B(+1.1%) |
| Dec 2012 | $4.44 B(-23.3%) | $872.00 M(-29.2%) | $4.44 B(+24.4%) |
| Sept 2012 | - | $1.23 B(+3.2%) | $3.57 B(+52.7%) |
| June 2012 | - | $1.19 B(+4.4%) | $2.34 B(+104.4%) |
| Mar 2012 | - | $1.14 B(-57.2%) | $1.14 B(-57.2%) |
| Dec 2011 | $5.79 B(+69.3%) | - | - |
| Dec 2010 | $3.42 B(+48.6%) | - | - |
| Dec 2009 | $2.30 B(-13.8%) | - | - |
| Dec 2008 | $2.67 B(-6.6%) | $2.67 B(-521.1%) | $2.67 B(+53.6%) |
| June 2008 | - | -$634.00 M(-200.0%) | $1.74 B(-41.1%) |
| Mar 2008 | - | $634.00 M(-19.2%) | $2.95 B(+3.3%) |
| Dec 2007 | $2.86 B(+48.6%) | $785.00 M(-17.6%) | $2.86 B(+10.1%) |
| Sept 2007 | - | $953.00 M(+64.3%) | $2.60 B(+17.7%) |
| June 2007 | - | $580.00 M(+7.4%) | $2.21 B(+8.5%) |
| Mar 2007 | - | $540.00 M(+3.1%) | $2.04 B(+5.8%) |
| Dec 2006 | $1.92 B(+18.6%) | $524.00 M(-6.9%) | $1.92 B(-1.0%) |
| Sept 2006 | - | $563.00 M(+38.0%) | $1.94 B(+3.5%) |
| June 2006 | - | $408.00 M(-4.7%) | $1.88 B(+6.5%) |
| Mar 2006 | - | $428.00 M(-21.3%) | $1.76 B(+8.8%) |
| Dec 2005 | $1.62 B(+24.8%) | $544.00 M(+9.2%) | $1.62 B(+14.1%) |
| Sept 2005 | - | $498.00 M(+69.4%) | $1.42 B(+13.4%) |
| June 2005 | - | $294.00 M(+3.2%) | $1.25 B(-1.7%) |
| Mar 2005 | - | $285.00 M(-17.2%) | $1.27 B(-1.8%) |
| Dec 2004 | $1.30 B(+1.2%) | $344.00 M(+4.2%) | $1.30 B(+1.2%) |
| Sept 2004 | - | $330.00 M(+4.4%) | $1.28 B(-2.4%) |
| June 2004 | - | $316.00 M(+2.3%) | $1.31 B(+2.1%) |
| Mar 2004 | - | $309.00 M(-6.1%) | $1.29 B(+0.4%) |
| Dec 2003 | $1.28 B(-0.9%) | $329.00 M(-8.9%) | $1.28 B(+34.5%) |
| Sept 2003 | - | $361.00 M(+24.9%) | $954.00 M(+60.9%) |
| June 2003 | - | $289.00 M(-4.9%) | $593.00 M(+95.1%) |
| Mar 2003 | - | $304.00 M | $304.00 M |
| Dec 2002 | $1.29 B(+24.9%) | - | - |
| Dec 2001 | $1.04 B(+39.9%) | - | - |
| Dec 2000 | $741.00 M(-21.8%) | - | - |
| Dec 1999 | $948.00 M(-6.0%) | - | - |
| Dec 1998 | $1.01 B | - | - |
FAQ
- What is Novartis AG annual depreciation & amortization?
- What is the all time high annual D&A for Novartis AG?
- What is Novartis AG annual D&A year-on-year change?
- What is Novartis AG quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Novartis AG?
- What is Novartis AG quarterly D&A year-on-year change?
- What is Novartis AG TTM depreciation & amortization?
- What is the all time high TTM D&A for Novartis AG?
- What is Novartis AG TTM D&A year-on-year change?
What is Novartis AG annual depreciation & amortization?
The current annual D&A of NVS is $8.28 B
What is the all time high annual D&A for Novartis AG?
Novartis AG all-time high annual depreciation & amortization is $8.28 B
What is Novartis AG annual D&A year-on-year change?
Over the past year, NVS annual depreciation & amortization has changed by +$1.57 B (+23.45%)
What is Novartis AG quarterly depreciation & amortization?
The current quarterly D&A of NVS is $1.97 B
What is the all time high quarterly D&A for Novartis AG?
Novartis AG all-time high quarterly depreciation & amortization is $4.53 B
What is Novartis AG quarterly D&A year-on-year change?
Over the past year, NVS quarterly depreciation & amortization has changed by -$1.15 B (-36.84%)
What is Novartis AG TTM depreciation & amortization?
The current TTM D&A of NVS is $6.03 B
What is the all time high TTM D&A for Novartis AG?
Novartis AG all-time high TTM depreciation & amortization is $8.51 B
What is Novartis AG TTM D&A year-on-year change?
Over the past year, NVS TTM depreciation & amortization has changed by -$2.48 B (-29.16%)